ACS CAN has endorsed the Give Kids A Chance bill and has joined the Alliance for Childhood Cancer in calling on Congress to pass this legislation. The bill would restore import incentives to developing drugs for children with cancer.
Progress in improving childhood cancer outcomes relies on regular, federal investment in childhood cancer research, including continued funding for the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act and Childhood Cancer Data Initiative (CCDI).
ACS CAN has been involved in a number of significant successes for childhood cancer appropriations including The Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act and Childhood Cancer Data Initiative (CCDI).
